TrialStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2023

[BRCA-like breast cancer patients benefit from cisplatin plus veliparib-results from the S1416 phase II study].

Katharina Hintelmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.